• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome.

作者信息

Tang Catherine, Lindsay Julian, Gill Anthony, Kerridge Ian

机构信息

Department of Haematology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.

Department of Haematology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.

出版信息

Clin Lymphoma Myeloma Leuk. 2017 Aug;17(8):539-541. doi: 10.1016/j.clml.2017.06.032. Epub 2017 Jun 30.

DOI:10.1016/j.clml.2017.06.032
PMID:28842141
Abstract
摘要

相似文献

1
Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome.去纤苷用于长春新碱诱导的肝窦阻塞综合征
Clin Lymphoma Myeloma Leuk. 2017 Aug;17(8):539-541. doi: 10.1016/j.clml.2017.06.032. Epub 2017 Jun 30.
2
Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.去纤苷钠用于治疗肝静脉闭塞性疾病/窦性阻塞综合征。
Expert Rev Clin Pharmacol. 2018 Feb;11(2):113-124. doi: 10.1080/17512433.2018.1421943. Epub 2018 Jan 5.
3
Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.去纤维肽在造血细胞移植后肝静脉闭塞性疾病患儿和成人中的应用。
Expert Rev Gastroenterol Hepatol. 2017 Oct;11(10):885-898. doi: 10.1080/17474124.2017.1370372. Epub 2017 Sep 4.
4
Sinusoidal Obstruction Syndrome (SOS) and Defibrotide: We Are Not There Yet.
Transplant Cell Ther. 2023 May;29(5):287-288. doi: 10.1016/j.jtct.2023.03.032.
5
Defibrotide: a review of its use in severe hepatic veno-occlusive disease following haematopoietic stem cell transplantation.去纤苷：造血干细胞移植后用于严重肝静脉闭塞病的应用综述
Clin Drug Investig. 2014 Dec;34(12):895-904. doi: 10.1007/s40261-014-0242-x.
6
In brief: Defibrotide (Defitelio) for hepatic veno-occlusive disease.简而言之：去纤苷（Defitelio）用于治疗肝静脉闭塞性疾病。
Med Lett Drugs Ther. 2016 Sep 12;58(1503):120.
7
"Pre-emptive strike"-the case for early treatment of hepatic sinusoidal obstruction syndrome with defibrotide.“先发制人”-用多黏菌素 B 脂质体预防治疗肝窦阻塞综合征。
Pediatr Blood Cancer. 2018 Jul;65(7):e27036. doi: 10.1002/pbc.27036. Epub 2018 Mar 14.
8
Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation.造血细胞移植后发生肝静脉闭塞病/窦状隙阻塞综合征且需要呼吸机或透析依赖的患者，在第 100 天defibrotide 治疗的生存汇总分析。
Br J Haematol. 2020 Aug;190(4):583-587. doi: 10.1111/bjh.16552. Epub 2020 Mar 10.
9
Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high-dose chemotherapy: A single-center experience from the Royal Marsden Hospital, UK.去纤维肽治疗而非预防在接受大剂量化疗后进行自体干细胞移植的儿童肝窦阻塞综合征中有用：来自英国皇家马斯登医院的单中心经验。
Pediatr Blood Cancer. 2020 Nov;67(11):e28677. doi: 10.1002/pbc.28677. Epub 2020 Aug 31.
10
Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.去纤维肽治疗造血干细胞移植后儿童肝静脉闭塞病。
Expert Rev Hematol. 2012 Jun;5(3):291-302. doi: 10.1586/ehm.12.18.

引用本文的文献

1
Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives.药物性肝窦阻塞综合征：当前进展与未来展望
Arch Toxicol. 2025 Mar;99(3):835-850. doi: 10.1007/s00204-024-03950-9. Epub 2024 Dec 24.
2
Hepatic Sinusoidal Obstruction Syndrome in a Patient With Multiple Myeloma Treated With CyBorD.接受CyBorD治疗的多发性骨髓瘤患者发生肝窦阻塞综合征
ACG Case Rep J. 2019 Jul 25;6(7):e00103. doi: 10.14309/crj.0000000000000103. eCollection 2019 Jul.
3
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.
地塞米松预防非移植相关化疗后肝静脉闭塞病/窦状隙阻塞综合征：扩展使用项目数据事后分析的最终结果。
Pediatr Blood Cancer. 2018 Oct;65(10):e27269. doi: 10.1002/pbc.27269. Epub 2018 Jun 6.